This Collaborative of the ACR® Learning Network seeks to improve clinically significant prostate cancer detection and localization.
Prostate MR image quality is inconsistent and unreliable, possibly leading to missed diagnosis of cancer and an inability to use the images in subsequent procedures.
Each facility forms an interdisciplinary project team consisting of four to six members who participate in the ACR® ImPower Program, alongside a cohort of colleagues from other institutions. Together, these teams will receive quality improvement (QI) education and utilize QI tools to identify and test ways to improve prostate MR image quality.
Suggested team members:
Prostate cancer is the most common solid noncutaneous cancer and the second most common cause of cancer-related death in men. When prostate MRI is used as a pre-biopsy triage method, there is increased detection of clinically significant cancers, reduced number of unnecessary biopsies and decreased healthcare costs. To improve prostate MR image quality, participating facilities are supported in identifying and evaluating opportunities within protocols, patient preparation, the development of technologist skill, communication between radiologists and technologists, agreement on image quality and data collection and reporting.
Andrei S. Purysko, MD
Associate Professor of Radiology, Cleveland Clinic Lerner College of Medicine; Head, Abdominal Imaging Section, Diagnostics Institute Staff, Nuclear Radiology and Glickman Urological and Kidney InstituteCleveland ClinicAndrei Purysko, MD, Clinical Assistant Professor of Radiology, Cleveland Clinic Lerner College of Medicine, is faculty for the ACR Education Center Prostate MR course and a member of the ACR Prostate MRI Center Designation Workgroup.
We’re here to help your team succeed. Please reach out with any questions to the ACR Learning Network team.
